Mellon is spurred on by public companies

Mellon HBV Alternative Strategies has launched a global risk arbitrage fund to capitalise on public company consolidations, which it believes have accelerated worldwide due to technological and regulatory changes, and globalisation.

The fund, which is available to investors for a minimum investment of $1m, opened with starting capital of $40m.

The fund's strategy is based on statistics that show an increase globally in mergers and acquisitions. According to Mergerstat and Dealogic, providers of US

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here